Matches in SemOpenAlex for { <https://semopenalex.org/work/W1702852910> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W1702852910 abstract "CN01-02 ETHNICITY AND PHARMACOGENETICS OF ANTICANCER THERAPY The human genome is 99.6-99.8% identical; however, 0.2-0.4% variation gives up to 10 million DNA variants, of which 10% may be found between populations of different geographical groups. When interethnic variation of variant frequencies exist in important genes that determine drug disposition or effects, population differences in drug toxicity or efficacy from standard doses of drug would be apparent. Recently, clinically important differences in warfarin dosing requirements between ethnic groups has been attributed mainly to genetic polymorphisms of its drug metabolising enzyme cytochrome P-450 2C9 (CYP2C9) and its target enzyme of inhibition vitamin K epoxide reductase (VKORC1). For anticancer drugs, activating mutations of the epidermal growth factor receptor tyrosine kinase (EGFR TK) domain are more common in Asian lung cancers, resulting in higher responses to EGFR TK inhibitors gefitinib and erlotinib. Docetaxel may have higher myelosuppression in Chinese than reported in literature when given at 75mg/m 2 q3w. In a phase II study, standard docetaxel/carboplatin for non-small cell lung cancer appears to more toxic but has a higher response rate in Singaporean compared to Australian patients. In a study population of 101 breast cancer patients receiving alternating cycles of single agent docetaxel and doxorubicin, Chinese patients had more myelosuppression from doxorubicin than Indian or Malay patients, and together with Indians had more myelosuppression than Malays. This interethnic variability in toxicity from chemotherapy was not explained by common polymorphisms in CYP3A5 , PXR , CAR or HNF4 α . Doxorubicin is metabolized intracellularly to doxorubicinol, a metabolite with 10-fold less cytotoxicity by short-chain dehydrogenases/reductases carbonyl reductases, CBR1 and CBR3. Therefore, we studied polymorphisms of CBR1 and CBR3 on doxorubicin pharmacokinetics and hematologic toxicity in this group of patients. CBR3 11G>A and 730G>A were common polymorphisms, and CBR3 11G>A (C4Y) was associated with lower conversion of doxorubicin to doxorubicinol, and consequently greater myelosuppression. Concordantly, Chinese had a lower frequency of the more active CBR11G allele than Indians, suggesting that this polymorphism may contribute to the interethnic variability of doxorubicin induced myelosuppression observed. An analysis of CBR3 RNA levels in tumour tissue showed higher expression in patients with CBR311GG genotype, suggesting increased transcriptional efficiency compared to the AA genotype. In summary, ethnogeographic factors may have significant impact on pharmacodynamic variability of anticancer drugs, and warrants more work to elucidate the genetic determinants of this variability." @default.
- W1702852910 created "2016-06-24" @default.
- W1702852910 creator A5010517284 @default.
- W1702852910 creator A5022870560 @default.
- W1702852910 creator A5033700679 @default.
- W1702852910 creator A5043184297 @default.
- W1702852910 date "2007-11-15" @default.
- W1702852910 modified "2023-09-27" @default.
- W1702852910 title "Ethnicity and Pharmacogenetics of Anticancer Therapy" @default.
- W1702852910 hasPublicationYear "2007" @default.
- W1702852910 type Work @default.
- W1702852910 sameAs 1702852910 @default.
- W1702852910 citedByCount "0" @default.
- W1702852910 crossrefType "journal-article" @default.
- W1702852910 hasAuthorship W1702852910A5010517284 @default.
- W1702852910 hasAuthorship W1702852910A5022870560 @default.
- W1702852910 hasAuthorship W1702852910A5033700679 @default.
- W1702852910 hasAuthorship W1702852910A5043184297 @default.
- W1702852910 hasConcept C104317684 @default.
- W1702852910 hasConcept C109650736 @default.
- W1702852910 hasConcept C121608353 @default.
- W1702852910 hasConcept C126322002 @default.
- W1702852910 hasConcept C135763542 @default.
- W1702852910 hasConcept C143998085 @default.
- W1702852910 hasConcept C196013638 @default.
- W1702852910 hasConcept C2776694085 @default.
- W1702852910 hasConcept C2778087573 @default.
- W1702852910 hasConcept C2779438470 @default.
- W1702852910 hasConcept C2780580887 @default.
- W1702852910 hasConcept C2781190966 @default.
- W1702852910 hasConcept C2781303535 @default.
- W1702852910 hasConcept C2908647359 @default.
- W1702852910 hasConcept C3946865 @default.
- W1702852910 hasConcept C526171541 @default.
- W1702852910 hasConcept C54355233 @default.
- W1702852910 hasConcept C55775858 @default.
- W1702852910 hasConcept C62231903 @default.
- W1702852910 hasConcept C71924100 @default.
- W1702852910 hasConcept C86803240 @default.
- W1702852910 hasConcept C98274493 @default.
- W1702852910 hasConcept C99454951 @default.
- W1702852910 hasConceptScore W1702852910C104317684 @default.
- W1702852910 hasConceptScore W1702852910C109650736 @default.
- W1702852910 hasConceptScore W1702852910C121608353 @default.
- W1702852910 hasConceptScore W1702852910C126322002 @default.
- W1702852910 hasConceptScore W1702852910C135763542 @default.
- W1702852910 hasConceptScore W1702852910C143998085 @default.
- W1702852910 hasConceptScore W1702852910C196013638 @default.
- W1702852910 hasConceptScore W1702852910C2776694085 @default.
- W1702852910 hasConceptScore W1702852910C2778087573 @default.
- W1702852910 hasConceptScore W1702852910C2779438470 @default.
- W1702852910 hasConceptScore W1702852910C2780580887 @default.
- W1702852910 hasConceptScore W1702852910C2781190966 @default.
- W1702852910 hasConceptScore W1702852910C2781303535 @default.
- W1702852910 hasConceptScore W1702852910C2908647359 @default.
- W1702852910 hasConceptScore W1702852910C3946865 @default.
- W1702852910 hasConceptScore W1702852910C526171541 @default.
- W1702852910 hasConceptScore W1702852910C54355233 @default.
- W1702852910 hasConceptScore W1702852910C55775858 @default.
- W1702852910 hasConceptScore W1702852910C62231903 @default.
- W1702852910 hasConceptScore W1702852910C71924100 @default.
- W1702852910 hasConceptScore W1702852910C86803240 @default.
- W1702852910 hasConceptScore W1702852910C98274493 @default.
- W1702852910 hasConceptScore W1702852910C99454951 @default.
- W1702852910 hasOpenAccess W1702852910 @default.
- W1702852910 hasRelatedWork W1535117950 @default.
- W1702852910 hasRelatedWork W1584091349 @default.
- W1702852910 hasRelatedWork W1849903145 @default.
- W1702852910 hasRelatedWork W2011628325 @default.
- W1702852910 hasRelatedWork W2026682807 @default.
- W1702852910 hasRelatedWork W2046359251 @default.
- W1702852910 hasRelatedWork W2064458956 @default.
- W1702852910 hasRelatedWork W2067171776 @default.
- W1702852910 hasRelatedWork W2085223528 @default.
- W1702852910 hasRelatedWork W2143464740 @default.
- W1702852910 hasRelatedWork W2144092358 @default.
- W1702852910 hasRelatedWork W2152332945 @default.
- W1702852910 hasRelatedWork W2310494837 @default.
- W1702852910 hasRelatedWork W2593507511 @default.
- W1702852910 hasRelatedWork W2769138394 @default.
- W1702852910 hasRelatedWork W2783645245 @default.
- W1702852910 hasRelatedWork W3021081493 @default.
- W1702852910 hasRelatedWork W3030238747 @default.
- W1702852910 hasRelatedWork W3136414142 @default.
- W1702852910 hasRelatedWork W2392902681 @default.
- W1702852910 hasVolume "13" @default.
- W1702852910 isParatext "false" @default.
- W1702852910 isRetracted "false" @default.
- W1702852910 magId "1702852910" @default.
- W1702852910 workType "article" @default.